- Home
- AXTI vs INCR Comparison
AXTI vs INCR Comparison
Compare AXTI & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXTI
- INCR
- Stock Information
- Founded
- AXTI 1986
- INCR 1994
- Country
- AXTI United States
- INCR Israel
- Employees
- AXTI N/A
- INCR N/A
- Industry
- AXTI Semiconductors
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- AXTI Technology
- INCR Health Care
- Exchange
- AXTI Nasdaq
- INCR Nasdaq
- Market Cap
- AXTI 84.8M
- INCR 84.5M
- IPO Year
- AXTI 1998
- INCR N/A
- Fundamental
- Price
- AXTI $2.56
- INCR $1.57
- Analyst Decision
- AXTI Strong Buy
- INCR
- Analyst Count
- AXTI 4
- INCR 0
- Target Price
- AXTI $4.69
- INCR N/A
- AVG Volume (30 Days)
- AXTI 728.8K
- INCR 23.5K
- Earning Date
- AXTI 07-31-2025
- INCR 08-15-2025
- Dividend Yield
- AXTI N/A
- INCR N/A
- EPS Growth
- AXTI N/A
- INCR N/A
- EPS
- AXTI N/A
- INCR N/A
- Revenue
- AXTI $96,029,000.00
- INCR $65,575,323.00
- Revenue This Year
- AXTI N/A
- INCR $69.54
- Revenue Next Year
- AXTI $27.18
- INCR $41.75
- P/E Ratio
- AXTI N/A
- INCR N/A
- Revenue Growth
- AXTI 21.44
- INCR N/A
- 52 Week Low
- AXTI $1.13
- INCR $1.17
- 52 Week High
- AXTI $4.03
- INCR $2.62
- Technical
- Relative Strength Index (RSI)
- AXTI 69.02
- INCR 57.30
- Support Level
- AXTI $1.97
- INCR $1.48
- Resistance Level
- AXTI $2.49
- INCR $1.56
- Average True Range (ATR)
- AXTI 0.15
- INCR 0.06
- MACD
- AXTI 0.02
- INCR 0.01
- Stochastic Oscillator
- AXTI 89.13
- INCR 89.20
About AXTI AXT Inc
AXT Inc is a developer and producer of compound and single element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.